Jörgen S. Axelsson
Partner, Member of the Swedish Bar AssociationProfile
I have more than 20 years of experience working in law firms and work mainly with transactions in capital markets and M&A.
Throughout my career, my focus has been capital markets and M&A. My assignments include advice in connection with IPOs, incentive programs, convertible issues, bond issues, public takeover bids and private M&A. My clients are often larger companies and banks in Sweden and abroad.
2013-,
Setterwalls
2001-2013,
Linklaters, Partner
2001,
Lagerlöf & Leman Advokatbyrå, Partner
1997-2001,
Lagerlöf & Leman Advokatbyrå
1994-1997,
Advokatfirman Wistrand
1993-1994,
Lagerlöf & Leman Advokatbyrå
1992-1993,
Amsterdam School of International Relations
1991-1992,
District Court of Stockholm, law clerk
1991,
Uppsala University, LL.M.
04 Nov 2024
Setterwalls advised Balder in connection with directed share issue of approximately SEK 1.5 billion05 Sep 2024
Setterwalls advised SLP in connection with a share issue of approximately SEK 1,100 million14 Jun 2024
Setterwalls has advised Flerie in connection with directed share issue of approximately SEK 607 million21 Feb 2024
Setterwalls has advised Balder in connection with directed share issue of approximately SEK 1.2 billion14 Dec 2023
Setterwalls advises Concordia Maritime in connection with Stena Sessan’s public takeover bid12 May 2023
Setterwalls has advised Rejlers in connection with directed share issue of approximately SEK 250 million05 May 2023
Setterwalls has advised SLP in connection with directed share issue of approximately SEK 550 million27 Feb 2023
Setterwalls has advised LIDDS AB (publ) in connection with rights issue of approximately SEK 48.6 million23 Feb 2023
Setterwalls advised Balder in connection with directed issue of convertibles of EUR 480 million19 Dec 2022
Setterwalls has advised Balder in connection with directed share issue of approximately SEK 1.8 billion05 Dec 2022
Setterwalls advised Balder in connection with tender offer on outstanding EUR capital securities20 Sep 2022
Setterwalls has assisted Balder in connection with tender offer on outstanding hybrid capital securities14 Sep 2022
Setterwalls has advised IRRAS AB in connection with rights issue of approximately SEK 215 million11 Apr 2022
Setterwalls has assisted Anoto Group in a development agreement with Samsung Display Company11 Jun 2021
Setterwalls has assisted Knowit in connection with directed share issue of approximately SEK 500 million11 Jun 2021
Setterwalls has advised Sivers Semiconductors in connection with listing on Nasdaq Stockholm18 Jan 2021
Setterwalls has advised Serneke in connection with rights issue of approximately SEK 170 million15 Dec 2020
Setterwalls advises the founders in connection with the public takeover bid for Recipharm together with EQT24 Nov 2020
Setterwalls has assisted Balder in connection with directed share issue of approximately SEK 2,945 million24 Sep 2020
Setterwalls has assisted Sivers IMA in connection with directed share issue of approximately SEK 200 million05 Feb 2020
Setterwalls has assisted Recipharm in connection with the acquisition of Consort Medical23 Jan 2020
Setterwalls advises Serneke in the sale of a majority stake in Karlatornet to Oaktree Capital Management20 Aug 2019
Setterwalls has assisted FSN Capital with the divestment of Velcora Holding AB (Roplan) to IDEX Corporation29 Aug 2018
Setterwalls has assisted Vivalto Santé in connection with the ongoing acquisition of Capio France25 Jun 2018
Setterwalls has assisted Recipharm in connection with directed share issue of approximately SEK 508 million08 Dec 2017
Setterwalls assisted Altigi GmbH and its sellers in connection with Stillfront’s acquisition of Goodgames27 Nov 2017
Setterwalls assists IRRAS in connection with IPO23 Nov 2016
Setterwalls assists Alligator Bioscience AB in connection with listing on Nasdaq Stockholm19 Dec 2014
Setterwalls advisor to SveaReal in connection with the largest property transaction in Scandinavia 201414 Nov 2014
Setterwalls advised Recipharm in connection with SEK 1 billion acquisition of Lusomedicameta15 Nov 2019
Great interest in Setterwall's FinTech ForumChambers Global (2018-2021)
Chambers Europe (2018-2022)
Legal 500 (2018-2022)
IFLR1000 (2019-2021)
Expert Guides
”Knowledgeable and technically skilled”
Chambers Global
”Clients admire Jörgen Axelsson 's ability to keep a "clear mind when thinking about complex matters". He has expertise in matters concerning public M&A and IPOs, and advised Promore Pharma on its share issue.”
Chambers Europe
”He is a very experienced and pragmatic lawyer.”
Chambers & Partners
”A really strong name.”
Chambers & Partners
”He is highly regarded amongst sources, who appreciate his very proactive, hands-on approach, and regard him as a great guy to work with.”
Chambers Europe
”A powerful partner who displays encyclopaedic legal knowledge and takes a constructive approach.”
Legal 500
”Technically skilled and experienced lawyer. Jörgen S Axelsson is favoured amongst commentators for his incredible working capacity and his sympathetic nature.”
Chambers & Partners
”Technically skilled and experienced lawyer.”
Chambers Global
”'Incredible working capacity and his 'sympathetic nature'.”
Chambers Global
”Excellent technical capacity.”
Chambers Europe
”The best capital markets lawyer in Sweden.”
Legal 500
”Very bright and skilled corporate lawyer. He is go-to person for complex transactions.”
Chambers